Publications by authors named "M Yeshurun"

Article Synopsis
  • High-dose therapy followed by autologous stem cell transplant (ASCT) has been the standard treatment for myeloma patients for 30 years, but the effectiveness of this approach is being questioned given new therapies.
  • A systematic review and meta-analysis examined whether using triplet therapy alone (without upfront ASCT) could provide similar outcomes for myeloma patients.
  • The results showed no significant difference in overall survival between both treatment approaches, but the upfront ASCT led to significantly better progression-free survival, particularly in patients with high-risk cytogenetics.
View Article and Find Full Text PDF

Purpose: We hereby describe a case of persistent cytomegalovirus (CMV) viremia and retinitis following allogeneic hematopoietic cell transplantation (HCT) that was successfully treated with infusion of CMV-specific cytotoxic T lymphocytes (CTL) despite previous treatment with Epstein Bar Virus (EBV) -specific CTL, which occurred 5 months earlier.

Observations: Following several anti- viral medication treatment trials that failed to eradicate the infectious process, the patient was treated with infusions of CMV-CTL from a biobank of cryopreserved virus-specific cells. Shortly after the first infusion, a remarkable response was noted.

View Article and Find Full Text PDF

Patients with FLT3-mutated acute myeloid leukaemia (AML) that relapse or are refractory (R/R) to intensive induction have poor outcomes. Gilteritinib has recently become standard-of-care for patients with R/R FLT3-mutated AML. We investigated whether adding venetoclax to gilteritinib (gilt-ven) improves outcomes as compared with gilteritinib monotherapy.

View Article and Find Full Text PDF

Listeriosis is rare after hematopoietic stem cell transplantation (HCT). Little is known about listeriosis in this population. In this retrospective international case-control study, we evaluated 41 listeriosis episodes occurring between 2000 and 2021 in HCT recipients (111 transplant centers in 30 countries) and assessed risk factors for listeriosis by comparisons with matched controls.

View Article and Find Full Text PDF

Introduction: Hemato-oncology patients are vulnerable to bloodstream infections due to immunocompromised state and use of intravascular catheters. Data regarding risk of infective endocarditis (IE) among those with gram-positive bacteremia are limited. We aimed to evaluate the incidence of IE among neutropenic hemato-oncology patients and explore the yield of echocardiogram in this population.

View Article and Find Full Text PDF